Home

Mesothelioma

• About Mesothelioma
• Mesothelioma Cause
• Mesothelioma Symptoms
• Mesothelioma Diagnosis
• Mesothelioma Stages

Mesothelioma Treatment

• Treatment Options
• Mesothelioma Surgery
• Mesothelioma Chemotherapy
• Mesothelioma Radiation
• New Approaches
• Palliative Care

Mesothelioma Specialists

• Choosing Your Doctor
• Your Health Care Team
• Cancer Centers

Clinical Trials

• Trial Basics
• Eligibility
• Current Trials

Managing Your Care

• Your Personal Records
• Your Medications
• Your Expenses

Veterans Resources

• Veterans' Mesothelioma Home
• Asbestos Exposure
• Asbestos Diseases
• VA Health Care
• Veterans Service Officers

NEWS ABOUT PHARMACEUTICALS IN MESOTHELIOMA TREATMENT

1. Targeting B-Cell Surface Proteins to Fight Cancer
2. Mesothelioma and Cancer Research - Human Epidermal Growth Factor Receptor (HER) Signaling and Cancer Therapy
3. Preparing for surgery - details to consider
4. Mesothelioma and Cancer Research - the Hedgehog signaling pathway and cancer therapy
5. Predicting the Effectiveness of Avastin
6. New Mesothelioma Detection Test Ready for Distribution
7. Mesothelioma Medication Alimta Receives Approval from UK Health Officials for Lung Cancer
8. New Maintenance Therapy Methods for Lung Cancer
9. Scientists at Karmanos Center Isolate Cause of Pleural Pain in Mesothelioma and Other Asbestos Diseases
10. New Chemotherapy Combination to be tested on Mesothelioma Patients
11. New Method Shows Promise in Improving Diagnostic Biomarker Cancer Tests
12. Finnish Study Could Lead to Better Lung Cancer Drug
13. New Lung Cancer Drug Starts Phase II Clinical Trial
14. Gene Screening Proves Effective in Screening for Mesothelioma Survival
15. Ohio University Finds Bond between Asbestos, Human Cell Tissue - Could Lead to Understanding of Mesothelioma Pathogenesis
16. New Drug Regimen Aimed at Reducing Chemotherapy-Induced Nausea
17. Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma
18. Gene Expression Ratio Test Can Predict Survival in Mesothelioma Cases
19. Personalized Treatment Prolongs Survival For Advanced Cancer Patients
20. BWH Researchers Identify Mutated Genes Unique to Mesothelioma Tumors - Brigham and Women's Hospital
21. Cancer Diagnosis From a Single Drop of Blood?
22. National mesothelioma virtual bank
23. Another Study Links Nanotubes To Mesothelioma
24. Retrofitted Antibodies Shrink Cancer Tumors and May Lead to HIV Vaccine
25. FDA Tells Manufacturers to Stop Marketing Bogus Cancer Cures
26. Morphotek Commences Phase II Study of MORAb-009 for Patients with MPM
27. Research Shows Altered Immune Cells Target Mesothelin
28. UK researchers predict rates of lung cancer will drop 20% over the next 20 years
29. Breakthrough Could Lead to New Cancer Therapies
30. Gene Fusions May Be Unique Identifier for Cancer
31. Study Examines Interactions Between Asbestos Fibers and Cells
32. Liver Tumors Treated with Chemotherapy Beads
33. Mesothelioma Researcher Receives Two Grants
34. The War on Mesothelioma: Researchers Announce Promising Results of Mesothelin-Based Immunotherapy
35. Synthetic Material Attaches to Cells to Assist in Cancer Research
36. Blood Vessel Growth Slowed with Common Chemotherapy Drugs, Slow Spread of Cancer
37. FDA Recommends Additional Clinical Trial for Onconase
38. ZenBio Awarded Phase II SBIR Grant for Cell Development
39. Researchers gain new insight into DNA replication
40. Study bolsters argument for treating cancer-related fatigue with exercise
41. Study finds new chemotherapies to be ineffective in fighting asbestos-related cancer
42. Researchers report promising gene that causes cancer cells to self destruct
43. EPA awards $2.1 million asbestos research grant
44. Cancer research may exclude older patients
45. Vitamin supplements may not help prevent cancer
46. New treatments under development for asbestos-related cancer
47. Cancer treatment errors happen more than commonly known
48. Scientists develop nanotube technology to fight cancer cells
49. Study Shows Brief Inhibition of Cancer Cells is Effective
50. Rosetta Genomics offers MicroRNA-based mesothelioma diagnostic test
51. Vitamin trials for cancer prevention offer disappointing results
52. Supressing tumors in young patients may increase cancer risk in later years
53. Mistakes in Treatment Prompt Thorough Review in Southern Australia Hospitals
54. Researchers Discover Enzyme That Signals Breast Cancer Metastasis
55. Woman Campaigns for UK Chemoembolisation Trials After Successful Treatment
56. Clinical trials struggling to attract participants
57. Study finds chemotherapy may be harmful For patients with advanced cancer
58. New cancer studies call anti-angiogenesis process into question
59. Scientists explore ways to use genes to fight cancer
60. Researchers find molecule that causes malignant cells to self-destruct
61. Research sheds light on lung cancer for non-smokers
62. Doctors look toward screening for lung cancer
63. Nanomaterial Screening helps determine which particles are toxic
64. Experts: Current pain treatment not sufficient for cancer patients
65. Massage could be beneficial for reducing cancer pain
66. New findings about chemotherapy at the molecular level
67. Transdermal patch developed for severe cancer pain
68. Too much Vitamin C may interfere with chemotherapy
69. New clues on causes of thoracic cancer
70. Telomerase gene sequence uncovered
71. Pleurodesis in the treatment and care of mesothelioma patients
72. Epigenetic drugs for cancer treatment
73. Study shows Alimta effective for maintenance therapy
74. Scientists announce advance in immunotherapy
75. Minimally invasive RFA treatment could be used for several cancer types
76. Novel strategy for cancer treatment uses patient's own blood
77. Attacking cancer stem cells a way to treat cancer
78. Predicting cancer-fighting abilities by computer
79. Anti-inflammatory drugs investigated for chemoprevention
80. Modified chemotherapy agent improves PET scan functioning
81. Government budget cuts deter progress in fight against cancer
82. Navelbine and cisplatin/pemetrexed in treatment of pleural mesothelioma
83. Tumor Generator Could Enhance Cancer Drug Development
84. Belgian doctors hit personalized cancer treatment milestone
85. New biomarkers for cancer developed
86. New cancer medicines track records fail to live up to hype
87. New research initiative to map genetic mutations behind cancer
88. Study suggests antioxidant supplements can have negative effects for cancer treatment patients.
89. Personalized medicine holds promise
90. Arenegyr Receives Orphan Drug Designation for Mesothelioma
91. Onconase Phase IIIb Trial Posts Mixed Results
92. Study finds inaccuracies in some cancer treatment research.
93. Piroxicam and Cisplatin Show Promise Against Mesothelioma CellsCarbon nanotubes may be as deadly as asbestos
94. New Study Tells Researchers How Cancer Spreads
95. Researchers uncover reasons for patients' adverse reactions to Cetuximab.
96. Study: Chemotherapy may not have any positive results on mesothelioma sufferers
97. Synthetic Molecules May Help Battle Cancer
98. Scientists Take a New Look at the Benefits of Fasting when Undergoing Chemotherapy
99. Exercise Shown to Fend Off Fatigue Caused by Cancer
100. Nanoparticles Could Deliver Cancer Drugs
101. Meta-analysis of cancer clinical trials finds 41 percent are superior to existing treatments
102. Vinflunine Shows Promise in Treating Malignant Pleural Mesothelioma
103. Synthetic Molecules Could Offer A Lower Cost Cancer Treatment Alternative
104. "Bacteria Therapy" Shows Promise in Initial Tests
105. New UCLA Machine May Kill Cancer Cells
106. Study raises doubts about some DNA-based drugs
107. Disease-Causing Bugs May Help Treat Cancer
108. New Cancer Vaccine Approved for Limited Use in Russia
109. New Therapy Targets Hepatitis C
110. Innovative New Cancer Treatment Idea Earns $1 Million Prize
111. Higher Doses of Chemotherapy Make No Difference in Small Cell Lung Cancer
112. Nanoparticles Help Advance Anticancer siRNA Therapy
113. Research at MIT Shows microRNA's Protective Role
114. Patients See Benefit From Self Reporting Symptoms Online
115. Cancer drugs from genetically modified chicken eggs
116. Researchers attempting to figure out how cancer grows
117. Antifolates - Chemotherapy drugs
118. Dopamine for cancer treatment
119. Concerns about anemia medications for cancer patients
120. Researchers Developing New Ways of Detecting Cancer
121. Recentin Study Ends
122. Phase II Study of Sutent ® Results Out
123. Terminally Ill Cancer Patients Given Hope in UK
124. New Finding on Correlation Between Angiogenesis, Breast Cancer and Inflammation
125. PET Found to be effective in the Evaluation of Cancer Treatment
126. One-tird of cancer patients experience chronic fatigue after treatment
127. New Drug Cocktails Hold Promise for Cancer, HIV Treatments.
128. New DNA Discovery Changes the Way Doctors Look at Cancer.
129. Inraperitoneal Hyperthermic Chemotherapy for Those Suffering With Abdominal Cancer
130. Mouse Model For Mesothelioma Reproduces Human Disease
131. Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignant Pleural Mesothelioma
132. Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
133. Remembering a researcher’s legacy on asbestos research
134. PET proves effective in evaluating cancer treatment
135. Trial on experimental antifolate PDX (Pralatrexate)
136. American College of Physicians releases guidelines for end-of-life care
137. Web-based system helps doctors track outpatients’ chemotherapy toxicity
138. NICE Gives Final Approval for Alimta
139. Par Pharmaceuticals licenses Onconase
140. Thalidomide and Alimta to be Combined in New Clinical Trial
141. Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
142. ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma
143. Boysenberries might impede mesothelioma
144. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
145. New Mesothelioma Research Center to Open in Sydney
146. Virotherapy to Treat Mesothelioma
147. MIT researchers' "nanocell" delivers a toxic double whammy to tumors
148. FDA Approves the MESOMARK® Assay for the Management of Mesothelioma Patients
149. NYU School of Medicine Verifies Mesothelioma Diagnostic Test
150. Researchers Identify Intracellular Pathway of Alfacell's Onconase
151. New Study Heralds Shortened Timeline for Anticancer Drug Development
152. Talcum Powder Stunts Tumor Growth
153. Soluble mesothelin in effusions a strong indicator of mesothelioma
154. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
155. New Technology For Cancer Screening Listens For The Signs Of Cancer
156. Onconase(®) is in its final phase 3 trial for treatment of patients with unresectable malignant mesothelioma
157. Data Affirm Benefit of ALIMTA(®) for Patients With Malignant Pleural Mesothelioma
158. New diagnostic tool for mesothelioma to be developed: test will extract microRNAs from a simple blood draw
159. The Barbara Ann Karmanos Cancer Institute announces significant scientific findings related to Malignant Mesothelioma
160. Mild Hyperthermia Enhances Antitumor Effects of Ranpirnase
161. Study shows Mesomark effective for monitoring Mesothelioma
162. FDA Grants Orphan Drug status to Onconase for Mesothelioma
163. Alfacell Corporation Files for U.S. Orphan Drug Designation for Onconase
164. Additional Data From a Phase I Trial of XL647 in Patients With Advanced Solid Tumors
165. New study on the safety, tolerability, pharmacokinetics and preliminary efficacy of INNO-305
166. More evidence that patients treated with Onconase have greater median survival times than patients treated with doxorubicin alone
167. Zolinza becomes first approved HDAC inhibitor
168. Alimta Researchers Recognized As Heroes Of Chemistry
169. Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
170. FDA tells Eli Lilly that their Alimta brochure is misleading
171. News about onocology product candidate SS1P (renamed CAT-5001)
172. New Research Shows Unique Promise of Onconase in the Prevention and Treatment of Mesothelioma
173. CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
174. Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
175. Alfacell Achieves Full Patient Enrollment Milestone for the Onconase Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
176. Scientist Reveals His Hopes for Better Tumour Treatment
177. Alfacell Drug Trial Ahead of Schedule
178. Alfacell Forms New Thoracic Cancer Advisory Board
179. Update on Onconase Clinical Program
180. Promising Research in Early Detection of Mesothelioma
181. Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
182. INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
183. Gene Drug Gives Mesothelioma Patient Second Chance
184. Novel therapies for pleural mesothelioma
185. Thoracic Cancer Patients Find New Reasons for Hope with Alimta(®)

MesotheliomaWeb News Stories

Read excerpts from medical publications

Contact Us

**For a FREE information packet including treatments, clinical trials, and specialists, please complete the form above or call a Mesothelioma Web coordinator at 1-877-367-6376.

News

• Mesothelioma News
• International News
• Pharmaceutical News
• Environmental News
• Medical Journal Articles

Resources

• Leading Cancer Links
• Financial Assistance, Compensation, and Legal Rights
• About Us
• Privacy Policy
• Disclaimer and Sponsorship Information

This site complies with the HONcode standard for trustworthy health information: verify here

If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:

Toll-Free 1-877-367-6376